GDS Wealth Management
- SEC CIK
- 0001940869
- Latest filing
- Aug 13, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by GDS Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 266,372
- Value
- $24.1M
- % of portfolio
- 1.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 266,372 | $24.1M | 1.1% | +18,760+7.6% | Added | Holders |
| Q1 2026 | 247,612 | $19.8M | 1.2% | +14,736+6.3% | Added | Holders |
| Q4 2025 | 232,876 | $19.9M | 1.2% | +6,878+3.0% | Added | Holders |
| Q3 2025 | 225,998 | $17.6M | 1.2% | +9,046+4.2% | Added | Holders |
| Q2 2025 | 216,952 | $17.0M | 1.2% | +10,333+5.0% | Added | Holders |
| Q1 2025 | 206,619 | $15.0M | 1.3% | +15,606+8.2% | Added | Holders |
| Q4 2024 | 191,013 | $14.1M | 1.3% | +60,339+46.2% | Added | Holders |
| Q3 2024 | 130,674 | $8.62M | 0.8% | −63,717−32.8% | Reduced | Holders |
| Q2 2024 | 194,391 | $18.0M | 2.0% | +6,764+3.6% | Added | Holders |
| Q1 2024 | 187,627 | $17.9M | 2.1% | +5,418+3.0% | Added | Holders |
| Q4 2023 | 182,209 | $13.9M | 1.9% | +90,328+98.3% | Added | Holders |
| Q3 2023 | 91,881 | $6.37M | 1.0% | +8,323+10.0% | Added | Holders |
| Q2 2023 | 83,558 | $7.88M | 1.3% | −13,296−13.7% | Reduced | Holders |
| Q1 2023 | 96,854 | $8.01M | 1.4% | +14,259+17.3% | Added | Holders |
| Q4 2022 | 82,595 | $6.16M | 1.2% | +19,642+31.2% | Added | Holders |
| Q3 2022 | 62,953 | $5.20M | 1.2% | +2,391+3.9% | Added | Holders |
| Q2 2022 | 60,562 | $5.76M | 1.3% | +22,357+58.5% | Added | Holders |
| Q1 2022 | 38,205 | $4.56M | 1.0% | +2,144+5.9% | Added | Holders |
| Q4 2021 | 36,061 | $4.67M | 1.0% | – | No prior filing | Holders |